Personalized anti-platelet therapy for high-risk patients after stent placement
Official title: A Randomized Comparison of TAILOReD Anti-Platelet Therapy According to Platelet Reactivity Versus Uniform Clopidogrel Monotherapy Beyond 12 Months After Drug-eluting Stent Implantation in High-risk Patients: TAILOR-DAPT
Run by Yonsei University · NCT05936606 · Data updated 2026-11-12
This study is testing if a personalized anti-platelet treatment can help high-risk patients who have had a stent placed feel better than just taking standard medication alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 80 Years |
| Sex | All |
| Enrollment | 3434 (estimated) |
| Sponsor | Yonsei University Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | August 16, 2023 |
| Main results expected | May 2027 |
| Study ends | May 2029 |
| Registry record updated | August 30, 2023 |
| Trial ID | NCT05936606 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients over 50 years old who have undergone DES implantation and exhibit high-risk characteristics for ischemic events.
✕Probably not a fit
Patients over 80 years old or those who are pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of a tailored anti-platelet therapy strategy for high-risk patients who have undergone drug-eluting stent (DES) placement. Participants will be randomly assigned to either continue standard clopidogrel monotherapy or receive personalized treatment based on their platelet reactivity. The intervention aims to optimize antiplatelet therapy beyond 12 months post-stenting, particularly for those with high platelet reactivity. The study will monitor outcomes over a period of up to 24 months.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of ischemic events and bleeding complications in high-risk patients after stent placement.
How similar studies have gone: Other studies have shown promise in personalized antiplatelet therapy, but this specific approach in high-risk DES patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients \> 18 years old 2. Patients who previously underwent percutaneous coronary intervention with drug-eluting stent implantation 12 months (± 3 months) ago. 3. At least one high risk characteristics of ischemic events High risk patients 1. Acute coronary syndrome 2. Previous history of cerebrovascular accidents 3. Previous history of peripheral artery intervention 4. Heart failure 5. Diabetes mellitus requiring medication 6. Chronic kidney disease (regardless of requirement of renal replacement therapy) High risk lesions 1. Left main disease 2. Multivessel disease, 2- or 3- vessels 3. Bifurcation lesions requiring 2 or more stents 4. Chronic total occlusion 5. In-stent restenosis 6. Graft lesions 7. Diffuse long lesion requiring stent(s) with total stent length ≥28 mm 8. Lesion at small sized vessel requiring stent(s) with stent diameter ≤2.5 mm 9. Calcified lesions requiring atherectomy Exclusion Criteria: 1. Patients \> 80 years old 2. Pregnant women or women with potential childbearing 3. Life expectancy \< 1 year 4. Refusal or inability to understand of informed consent 5. Patients eligible to long-term anticoagulation therapy 6. Patients with major bleeding events in previous 3 months before randomization
Where it's running
-
Severance Hospital
Seoul, South Korea Recruiting
Study contacts
- Principal investigator: Byeong-Keuk Kim — Severance Cardiovascular Hospital
- Study coordinator: Byeong-Keuk Kim
- Email: kimbk@yuhs.ac
- Phone: 02-2228-8465
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.